DREDGECAP
NASDAQ·Orthopedic, Prosthetic & Surgical Appliances & Supplies

ISRGINTUITIVE SURGICAL INC

Last filing: 8-K·May 4, 2026EDGAR ↗
ISRG Overview
10-QOctober 18, 202410/18/24· Quarter Ended September 30, 2024· Q-End 9/30/24

ISRG10-Q Filing

Track for Alerts

Financial Highlights

Structured-data extract from the filer's SEC-tagged XBRL. Every value below is sourced from a labeled XBRL concept; hover any cell to see the exact source. No AI summarization, no paraphrasing.

Income Statement

ItemSep 30, 2024Sep 30, 2023YoY
Revenue$2.04B$1.74B↑ +16.9%
Cost of Revenue$664.20M$576.50M
Operating Income (Loss)$577.30M$465.80M↑ +23.9%
Net Loss from Continuing Operations(derived)$565.10M$415.70M↑ +35.9%
Net Income (Loss) — Total$565.10M$415.70M↑ +35.9%

Balance Sheet

ItemSep 30, 2024Sep 30, 2023YoY
Total Assets$17.74B$14.71B
Total Liabilities$2.07B$2.09B
Stockholders' Equity$15.58B$12.54B↑ +24.3%
Accumulated Deficit$6.13B$4.21B
Cash and Cash Equivalents$2.41B$3.60B↓ -33.0%
Shares Outstanding356.20M352.00M
Source filings — every value above is extracted verbatim from these SEC submissions:
Current DredgeCap Risk Profile
2.1/10
LOW RISK
Dilution Risk
LOW1.5/10
Liquidity Risk
LOW1.2/10
Debt Toxicity
LOW1.3/10
Profitability Risk
LOW1.8/10
Going Concern✓ Not flagged
The risk profile above reflects the latest cached DredgeCap analysis for ISRG. For the full filing-by-filing analyst report (red flags, primary risk driver, what moves the stock), open ISRG's company page.

What is a 10-Q?

A quarterly report covering the three months just ended. Includes unaudited condensed financial statements (balance sheet, income statement, cash flow), Management Discussion and Analysis (MD&A), and disclosure of material changes since the last annual report. Required for the first three fiscal quarters; the fourth quarter is rolled into the 10-K.

More on ISRG

Dilution Analysis
Debt Structure
Going Concern
Full Financials
Form-type explainers and 8-K item descriptions are derived from SEC documentation. Financial values are extracted from SEC-tagged XBRL — see the "Source filings" list above each table for direct EDGAR links to every cited filing. This page does not constitute investment advice. Always consult the original filing on SEC EDGAR for authoritative content, and consult a licensed financial advisor for investment decisions.